National Hospital Organization

Osaka 540-0006

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Breast Cancer

Studies at this site

• Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) — Completed